End of the Bedaquiline patent - a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries
1 Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark; European Society for Clinical Microbiology and Infectious Diseases Task Force for Emerging Infections, Basel, Switzerland; International Society for Infectious Diseases. Electronic address: eskild.petersen@gmail.com.
2 Department of Medicine & Therapeutics and Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China. Electronic address: dschui@cuhk.edu.hk.
3 Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Division of Infectious Diseases, Department of Medicine, Stellenbosch University, Faculty of Medicine and Health Sciences Cape Town, South Africa. Electronic address: jbn16@pitt.edu.
4 Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of Congo; Institute of Tropical Medicine, University of Tübingen, Germany. Electronic address: fntoumi@fcrm-congo.com.
5 International Society for Infectious Diseases; Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00149 Rome, Italy. Electronic address: delia.goletti@inmi.it.
6 Division of Clinical Pharmacology, Department of Global Public Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Electronic address: Eleni.Aklillu@ki.se.
7 Department of Biotechnology National Centre for Cell Science, Pune, India. Electronic address: avinash.nccs@gmail.com.
8 European Developing Countries Clinical rials partnership (EDCTP) Africa Office, Cape Town, South Africa. Electronic address: nyirenda@edctp.org.
9 Bacteriology Department, Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana. Electronic address: DYeboah-Manu@noguchi.ug.edu.gh.
10 Department of Microbiology, UCL Hospitals NHS Foundation Trust, London, United Kingdom. Electronic address: giovanni.satta@nhs.net.
11 Coalition for Epidemic Preparedness Innovations, Washington, DC, USA. Electronic address: chrisdacosta26@gmail.com.
12 Special Infectious Agents Unit BSL-3, King Fahd Medical Research Center, and Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: eazhar@kau.edu.sa.
13 International Society for Infectious Diseases; European Developing Countries Clinical rials partnership (EDCTP) Africa Office, Cape Town, South Africa; School of Community Health Sciences, Njala University, Bo, Sierra Leone. Electronic address: bockarie@edctp.org.
14 Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman. Electronic address: salabri@gmail.com.
15 Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK. Electronic address: t.mchugh@ucl.ac.uk.
16 Master's Program of Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru; Gilbert and Rose- Marie Chagoury School of Medicine, Lebanese American University, Beirut 1102, Lebanon. Electronic address: arodriguezmo@cientifica.edu.pe.
17 Department of Medicine and Infectious Diseases, Christian Medical College, Vellore, India. Electronic address: georgemvarghese@hotmail.com.
18 Department of Infection, Division of Infection and Immunity, Centre for Clinical Microbiology, University College London and NIHR Biomedical Research, Centre, University College London Hospitals NHS Foundation Trust, London NW1 OPE, UK. Electronic address: a.zumla@ucl.ac.uk.